Apyx Medical (APYX) Income towards Parent Company (2016 - 2026)
Apyx Medical filings provide 14 years of Income towards Parent Company readings, the most recent being -$1.2 million for Q4 2025.
- On a quarterly basis, Income towards Parent Company rose 82.57% to -$1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$11.1 million, a 57.31% increase, with the full-year FY2025 number at -$11.1 million, up 57.31% from a year prior.
- Income towards Parent Company hit -$1.2 million in Q4 2025 for Apyx Medical, up from -$2.0 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$1.0 million in Q2 2023 to a low of -$9.6 million in Q4 2023.
- Median Income towards Parent Company over the past 5 years was -$4.7 million (2023), compared with a mean of -$4.7 million.
- Biggest five-year swings in Income towards Parent Company: plummeted 546.32% in 2024 and later surged 82.57% in 2025.
- Apyx Medical's Income towards Parent Company stood at -$2.0 million in 2021, then crashed by 201.74% to -$6.1 million in 2022, then crashed by 58.68% to -$9.6 million in 2023, then grew by 26.08% to -$7.1 million in 2024, then surged by 82.57% to -$1.2 million in 2025.
- The last three reported values for Income towards Parent Company were -$1.2 million (Q4 2025), -$2.0 million (Q3 2025), and -$3.7 million (Q2 2025) per Business Quant data.